In parallel, the G-CIMP/IDH-mutant context-enriched within proneural tumours and associated with improved outcome is what supports the need to interpret autophagy-marker prognostic studies in a subtype-aware manner, as baseline metabolism and stress responses differ substantially from IDH-wild type GBM [95,96]. The gene discussed is IDH1; the disease is neoplasm.